Open Access<p>The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain</p>
Author(s) -
Neziha Erken,
Fatma Sena Dost Günay,
Pınar Soysal,
Ahmet Turan Işık
Publication year - 2020
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s252229
Subject(s) - medicine , cognition , radiation therapy , affect (linguistics) , breast cancer , anastrozole , cancer , pediatrics , surgery , psychiatry , tamoxifen , linguistics , philosophy
Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.